Esophageal dysmotility and other preoperative factors associated with acid suppressive therapy after fundoplication

Abstract

Abstract Background and aims: Acid suppressive therapy (AST) is frequently used after fundoplication. Prior studies show that most patients requiring AST after fundoplication have normal esophageal acid exposure and therefore do not need AST. Our aim was to determine the indications for AST use following fundoplication and the associated factors. Methods: Retrospective analysis of patients who underwent fundoplication at our institution between 2006 and 2013 with pre and postoperative esophageal physiologic studies was performed. Demographic data, symptoms, and findings on high resolution manometry, esophageal pH monitoring and upper endoscopy were collected. Results: Three hundred and thirty-nine patients were included with a median follow up time of 12.8[2.6, 47.7] months. Mean age was 59.6\u2009±\u200913.3\u2009years and 71.4% were women. Of those, 39.5% went on AST following fundoplication with a median time to AST use of 15.7[2.8, 36.1] months. The most common reason for AST use was heartburn. Only 29% of patients had objective evidence of acid reflux. Preoperative factors associated with AST use following fundoplication were male gender (HR1.6, p\u2009=\u20090.019), esophageal dysmotility (HR1.7, p\u2009=\u20090.004), proton pump inhibitor use (HR2.3, p\u2009<\u20090.001) and prior history of fundoplication (HR1.8, p\u2009=\u20090.006). In those with paraesophageal hernia repair with Collis gastroplasty (N\u2009=\u2009182), esophageal dysmotility (HR1.7, p\u2009=\u20090.047) and NSAID use (HR1.9, p\u2009=\u20090.023) were associated with AST use postoperatively. Discussion: AST use is common after fundoplication. Male gender, preoperative esophageal dysmotility, proton pump inhibitor use and redo fundoplication were associated with AST use following fundoplication. In those undergoing combined Collis gastroplasty, preoperative NSAID use and esophageal dysmotility predicted AST use.